指南与共识腹部MRUSCT

肝胆特异性磁共振对比剂与超声造影在肝细胞癌无创诊断中的新兴作用:聚焦主要指南的最新更新

Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines.
指南 / 共识 · Korean J Radiol · 2019-01-01

本文综述肝胆期MRI与超声造影在肝细胞癌无创诊断中的新兴作用,并回顾主要指南中肝细胞癌诊断标准的变化,包括2018年版KLCA-NCC实践指南,同时关注无创诊断中尚存的问题。

要点

  • 2018年主要指南将肝胆特异性对比剂MRI纳入肝细胞癌一线诊断检查。
  • KLCA-NCC与EASL指南将超声造影列为二线诊断检查。
  • 肝胆期MRI与超声造影将越来越多用于肝细胞癌的无创诊断与分期。

核心结论

  • 肝胆特异性磁共振对比剂与超声造影在肝细胞癌无创诊断和分期中的应用将日益增多。
  • 主要指南已更新肝细胞癌无创诊断标准,将肝胆特异性对比剂MRI纳入一线诊断检查,KLCA-NCC和EASL指南将超声造影列为二线诊断检查。

研究设计与样本

  • 综述,讨论肝胆期MRI与超声造影在肝细胞癌诊断中的作用,并回顾主要指南中肝细胞癌诊断标准的变化,包括2018年版KLCA-NCC实践指南。

关键影像表现/征象

  • 肝硬化患者中,肝细胞癌可基于CT和MRI上动脉期强化及门脉期/延迟期「廓清」的特征性影像表现进行无创诊断。

诊断标准与关键数值

  • 肝细胞癌无创诊断依据为动脉期强化及门脉期/延迟期「廓清」的特征性影像表现。
  • 2018年美国肝病研究学会、EASL、KLCA-NCC等主要指南更新将肝胆特异性对比剂MRI纳入一线诊断检查。
  • KLCA-NCC与EASL指南将超声造影列为二线诊断检查。

临床应用与阅片要点

  • 肝硬化患者可基于动脉期强化及门脉期/延迟期「廓清」的影像表现对肝细胞癌进行无创诊断。
  • 肝胆特异性对比剂MRI可作为一线诊断检查,超声造影可作为二线诊断检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Hepatocellular carcinoma (HCC) can be noninvasively diagnosed on the basis of its characteristic imaging findings of arterial phase enhancement and portal/delayed "washout" on computed tomography (CT) and magnetic resonance imaging (MRI) in cirrhotic patients. However, different specific diagnostic criteria have been proposed by several countries and major academic societies. In 2018, major guideline updates were proposed by the Association for the Study of Liver Diseases, European Association for the Study of the Liver (EASL), Korean Liver Cancer Association and National Cancer Center (KLCA-NCC) of Korea. In addition to dynamic CT and MRI using extracellular contrast media, these new guidelines now include magnetic resonance imaging (MRI) using hepatobiliary contrast media as the first-line diagnostic test, while the KLCA-NCC and EASL guidelines also include contrast-enhanced ultrasound (CEUS) as the second-line diagnostic test. Therefore, hepatobiliary MR contrast media and CEUS will be increasingly used for the noninvasive diagnosis and staging of HCC. In this review, we discuss the emerging role of hepatobiliary phase MRI and CEUS for the diagnosis of HCC and also review the changes in the HCC diagnostic criteria in major guidelines, including the KLCA-NCC practice guidelines version 2018. In addition, we aimed to pay particular attention to some remaining issues in the noninvasive diagnosis of HCC.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Kim TH, Yoon JH, Lee JM, et al. Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines. Korean J Radiol. 2019. PMID: 31132813. doi:10.3348/kjr.2018.0450

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。